IGF1 and ischemic stroke: We further demonstrated the therapeutic potentials of cyclocreatine in ischemic stroke, by enhancing microglial OXPHOS and facilitating its conversion from dystrophic microglia toward neuroprotective state, possibly via activation of Igf1.